Browse products

Distribution on the pharmaceutical market in Central Europe 2010

Comparative analysis of Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria

Distribution on the pharmaceutical market in Central Europe 2010 Comparative analysis of Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria

March 2010
Pages: 177
Delivery: PDF


Our clients say... 
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. General Manager, Sanofi-Synthelabo
We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis. General Manager, Sanofi-Synthelabo
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley

Distribution in the pharmaceutical market in Central Europe 2010 provides an in-depth analysis of distribution in the pharmaceutical sector in six Central European countries including Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria.


The report examines specific distribution channels in each country comprising:

  • wholesale
  • pharmacy sales
  • non-pharmacy sales
  • mail-order.

Analysis of both wholesale and pharmacy distribution is presented using a focus on a number of market players, profiles of leading distributors and a regulatory analysis for each country. It also includes comparative analysis of distribution systems between the countries.


The report is indispensable as a source of market analysis and industry data for keeping up to date with the latest market trends. It is an essential read if you search for:

  • operators and market entrants interested in distribution and sales in the pharmaceutical sector in Central Europe
  • senior executives in consulting and research firms, trade and industry organisations, government institutions and investment funds, monitoring pharmaceutical sales markets in Central Europe
  • market analysts and industry consultants involved in the pharmaceutical distribution sector in Central Europe.

Request sample pages/interactive screenshare

To receive more information on this report, please sign up.

*required

*Would you like a FREE
interactive screenshare?
*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:

Privacy Policy

  1. Report methodology

  2. Executive summary

  3. Main trends and events in the distribution segment 2008-2012

    • Poland
    • Hungary
    • Romania
    • Czech Republic
    • Slovakia
    • Bulgaria
  4. Wholesale distribution

    • Poland
      • Number of pharmaceutical wholesalers
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Hungary
      • Number of pharmaceutical wholesalers
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Romania
      • Number of wholesalers
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Czech Republic
      • Number of pharmaceutical wholesalers
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Slovakia
      • Number of pharmaceutical wholesalers
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Bulgaria
      • Number of pharmaceutical wholesalers
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Comparative analysis of wholesale distribution in Central Europe
      • Number of pharmaceutical wholesalers
      • Number of pharmacies per wholesale warehouse
      • Concentration of market players
  5. Pharmacy distribution

    • Poland
      • Number of pharmacies
        • Legal regulations
        • Largest market players
          • Profiles of selected key players
    • Hungary
      • Number of pharmacies
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Romania
      • Number of pharmacies
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Czech Republic
      • Number of pharmacies
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Slovakia
      • Number of pharmacies
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Bulgaria
      • Number of pharmacies
      • Legal regulations
      • Largest market players
        • Profiles of selected key players
    • Comparative analysis of pharmacy distribution in Central Europe
      • Number of pharmacy outlets
      • Ratio of population to number of pharmacies
      • Largest market players
  6. Non-pharmacy sales

    • Poland
    • Hungary
    • Romania
    • Czech Republic
    • Slovakia
    • Bulgaria
    • Comparative analysis of non-pharmacy distribution in Central Europe
  7. Online sales

    • Poland
      • Legal regulations
      • Number of internet pharmacies
      • Consumer behaviour
    • Hungary
      • Legal regulations
      • Number of internet pharmacies
    • Romania
    • Czech Republic
      • Legal regulations
      • Number of internet pharmacies
    • Slovakia
      • Legal regulations
      • Number of internet pharmacies
      • Consumer behaviour
    • Bulgaria
    • Comparative analysis of online sales in Central Europe
  8. List of graphs

  9. List of tables

  10. About PMR

  11. Contact PMR

List of graphs

  1. Proportion of Czechs buying toiletries, cosmetics and OTC drugs at drugstores (%), 2000-2008
  2. Location of pharmaceutical wholesalers’ warehouses in Poland, by voivodship, November 2009
  3. Number of pharmaceutical wholesalers’ warehouses with licences for trade in specific ranges of medical products, by type of products sold, November 2009
  4. Market shares of largest players on the pharmaceutical wholesale market in Poland, by sales to pharmacies, January 2010
  5. xxx group’s wholesale logistics structure in Poland, 2009
  6. xxx  group sales revenues (€ m) and their dynamics in Poland, 2003-2009
  7. xxx  group’s wholesale logistics structure in Poland, 2009
  8. xxx sales revenues (€ m) and their dynamics in Poland, 2004-2009
  9. xxx group’s wholesale logistics structure in Poland, 2009
  10. xxx  group sales revenues (€ m) and their dynamics, 2003-2009
  11. Sales structure of the xxx group, by division, 2009
  12. xxx  wholesale distribution logistics structure in Poland, 2009
  13. xxx  wholesale revenues (€ m) and their dynamics in Poland, 2005-2009
  14. xxx  wholesale distribution logistics structure in Poland, 2009
  15. xxx  sales revenues (€ m) and their dynamics in Poland, 2004/2005-2008/2009
  16. Estimated market shares of selected largest players on the pharmaceutical wholesale market in Hungary, by sales to pharmacies and hospitals, January 2010
  17. xxx  wholesale logistics structure in Hungary, 2010
  18. xxx  sales revenues (€ m) and their dynamics in Hungary, 2006-2008
  19. xxx  wholesale logistics structure in Hungary, 2010
  20. xxx  sales revenues (€ m) and their dynamics in Hungary, 2006/2007-2008/2009
  21. xxx wholesale logistics structure in Hungary, 2010
  22. xxx  turnover (€ m) and its dynamics in Hungary, 2007-2008
  23. Market shares of largest players on the pharmaceutical wholesale market in Romania, by sales to pharmacies and hospitals, July 2009
  24. xxx  wholesale logistics structure in Romania, 2010
  25. xxx  sales revenues (€ m) and their dynamics in Romania, 2003-H1 2009
  26. xxx  sales structure in Romania, by product groups, H1 2009
  27. xxx wholesale logistics structure in Romania, 2010
  28. xxx  sales revenues (€ m) and their dynamics in Romania, 2007-2009
  29. xxx sales structure in Romania, by product groups, 2008
  30. xxx  wholesale logistics structure in Romania, 2010
  31. xxx  turnover (€ m) and its dynamics in Romania, 2002-2009
  32. xxx  sales structure in Romania, by product groups, 2008
  33. xxx  International and Relad Pharma sales revenues and their dynamics in Romania (€ m), 2007-2008
  34. xxx  Pharma sales structure in Romania, by product groups, 2008
  35. xxx  wholesale logistics structure in Romania, 2010
  36. xxx  sales revenues (€ m) and their dynamics in Romania, 2006-2009
  37. xxx  sales structure in Romania, by product groups, 2009
  38. xxx  wholesale logistics structure in Romania, 2010
  39. xxx  sales revenues (€ m) and their dynamics in Romania, 2002-2008
  40. xxx  sales structure in Romania, by product groups, 2008
  41. xxx  wholesale logistics structure in Romania, 2010
  42. xxx  sales revenues (€ m) and their dynamics in Romania, 2002-2009
  43. xxx  sales structure in Romania, by product groups, 2008
  44. Number of warehouses operated by selected pharmaceutical wholesalers in the Czech Republic, January 2010
  45. Market shares of largest players on the pharmaceutical wholesale market in the Czech Republic, by sales to pharmacies and hospitals, January 2010
  46. xxx  wholesale logistics structure in the Czech Republic, 2010
  47. xxx  sales revenues (€ m) and their dynamics in the Czech Republic, February 2005-January 2009
  48. xxx  sales structure in the Czech Republic, by product groups, 2008
  49. xxx  wholesale logistics structure in the Czech Republic, 2010
  50. xxx  sales revenues (€ m) and their dynamics in the Czech Republic, April 2006-March 2009
  51. xxx  sales structure in the Czech Republic, by product groups, 2008
  52. xxx  wholesale logistics structure in the Czech Republic, 2010
  53. xxx  sales revenues (€ m) and their dynamics in the Czech Republic, 2002-2008
  54. Sales revenues (€ m) of xxx distribution companies in the Czech Republic, 2008
  55. xxx  wholesale logistics structure in the Czech Republic, 2010
  56. xxx  sales revenues (€ m) and their dynamics in the Czech Republic, 2006-Q3 2009
  57. Number of pharmaceutical wholesale warehouses in Slovakia, by location, January 2009
  58. Market shares of largest players on the pharmaceutical wholesale market in Slovakia, by sales to pharmacies, 2008
  59. Number of warehouses operated by selected pharmaceutical wholesalers in Slovakia, January 2009
  60. xxx  wholesale logistics structure in Slovakia, 2010
  61. xxx  sales revenues (€ m) and their dynamics in Slovakia, February 2005-January 2008
  62. xxx  sales structure in Slovakia, by product groups, 2008
  63. xxx  wholesale logistics structure in Slovakia, 2010
  64. xxx  sales revenues (€ m) and their dynamics in Slovakia, 2004-2009
  65. xxx  sales structure in Slovakia, by category of client, 2008
  66. xxx wholesale logistics structure in Slovakia, 2010
  67. xxx sales revenues (€ m) and their dynamics in Slovakia, 2005-2007
  68. xxx sales structure in Slovakia, by product groups, 2008
  69. xxx  wholesale logistics structure in Slovakia, 2010
  70. xxx  sales revenues (€ m) and their dynamics in Slovakia, 2004-2007
  71. Number of pharmaceutical wholesale warehouses in Bulgaria, by location, September 2009
  72. Number of warehouses operated by selected pharmaceutical wholesalers in Bulgaria, September 2009
  73. Market shares of largest players on the pharmaceutical wholesale market in Bulgaria, 2009
  74. xxx  wholesale logistics structure in Bulgaria, 2010
  75. Number of xxx clients (pharmacies and hospitals), January 2007, 2008, 2009 and 2010
  76. xxx  sales revenues and profit in Bulgaria (€ m), 2007-2009
  77. xxx  sales structure in Bulgaria, by division, H1 2009
  78. xxx  wholesale logistics structure in Bulgaria, 2010
  79. xxx turnover (€ m) and its dynamic in Bulgaria, 2006-2008
  80. xxx  wholesale logistics structure in Bulgaria, 2010
  81. xxx  turnover (€ m) and its dynamic in Bulgaria, 2007-2008
  82. xxx  wholesale logistics structure in Bulgaria, 2010
  83. xxx  turnover (€ m) and its dynamic in Bulgaria, 2006-2009
  84. Number of pharmacy outlets per one pharmaceutical warehouse in selected Central European countries, February 2010
  85. Number of pharmacy outlets in Poland, by category, December 2009
  86. Selected largest pharmacy chains in Poland, by number of outlets, February 2010
  87. Number of pharmacy outlets operated by xxx in Poland, by name, December 2009
  88. Number of pharmacy outlets operated by xxx in Poland, by name, January 2010
  89. xxx  retail sales revenues in Poland (€ m) and their dynamics, 2005-2009
  90. Revenues and net profit/loss of  xxx in Poland (€ m), 2004-2008
  91. Revenues and net profit/loss of  xxx in Poland (€ m), 2003-2008
  92. Number of pharmacy outlets in Hungary, by category, February 2010
  93. Selected largest pharmacy chains in Hungary, by number of outlets, February 2010
  94. Number of pharmacy outlets operated by xxx , by category of outlet, February 2010
  95. Number of pharmacy outlets operated by xxx , by location, February 2010
  96. Number of pharmacy outlets in Romania, by category, 2008
  97. Selected largest pharmacy chains in Romania, by number of outlets, February 2010
  98. Monthly sales revenues of pharmacies in Romania, 2009
  99. xxx  sales structure in Romania, by product groups, H1 2009
  100. xxx  sales revenues (€ m) and their dynamics in Romania, 2003-H1 2009
  101. xxx revenues in Romania, by category of pharmacy, H1 2009
  102. xxx  sales revenues (€ m) and their dynamics in Romania, 2007-Q3 2009
  103. xxx  revenues (€ m) and their dynamics in Romania, 2007-Q1 2009
  104. xxx  structure in Romania, by product groups, 2008
  105. xxx  sales revenues (€ m) from wholesale and retail activity and their dynamics in Romania, 2007-2009
  106. xxx  sales structure in Romania, by product groups, 2008
  107. xxx sales revenues (€ m) and their dynamics in Romania, 2002-Q3 2009
  108. xxx sales structure in Romania, by product groups, 2008
  109. xxx  sales revenues (€ m) and their dynamics in Romania, 2007-Q3 2009
  110. xxx  sales structure in Romania, by product groups, 2008
  111. xxx  sales revenues (€ m) and their dynamics in Romania, 2006-2009
  112. xxx  sales structure in Romania, by product groups, 2009
  113. xxx  sales revenues (€ m) and their dynamics in Romania, 2003-2009
  114. Number of new pharmacies and pharmacy points opened in the Czech Republic, 2006-2009
  115. Selected largest pharmacy chains in the Czech Republic, by number of outlets, February 2010
  116. Spontaneous and assisted recall of the names of pharmacy chains in the Czech Republic, June 2009
  117. Number of pharmacy outlets operated by xxx in the Czech Republic, by location, 2010
  118. Turnover and net profit of xxx in the Czech Republic (€ m), 2007 and 2008
  119. Revenues and net profit/loss of xxx in the Czech Republic (€ m), 2006-January 2009
  120. xxx  sales revenues (€ m) and their dynamics in the Czech Republic, 2006-Q3 2009
  121. xxx  sales revenues (€ m) and their dynamics in the Czech Republic, 2007-2008
  122. Number of pharmacies in Slovakia, by region, February 2010
  123. Number of pharmacies per 1,000 inhabitants in Slovakia, by region, February 2010 1
  124. Number of pharmacies per 100 km2 in Slovakia, by region, February 2010
  125. Selected largest pharmacy chains in Slovakia, by number of outlets, February 2010
  126. Number of pharmacies operated by xxx in Slovakia, by region, February 2010
  127. xxx  revenues (€ m) and their dynamics in Slovakia, 2007-2009
  128. Sales structure of xxx in Slovakia, by product groups, 2008
  129. Number of pharmacies operated by xxx in Slovakia, by region, February 2010
  130. xxx  sales revenues (€ m) and their dynamics in Slovakia, 2007-2008
  131. xxx  sales structure in Slovakia, by product groups, 2008
  132. Number of pharmacies operated byxxx in Slovakia, by region, February 2010
  133. xxx  sales structure in Slovakia, by product groups, 2008
  134. Number of pharmacies operated by xxx in Slovakia, by region, February 2010
  135. Selected largest pharmacy chains in Bulgaria, by number of outlets, February 2010
  136. Number of pharmacy outlets operated by xxx e in Bulgaria, by name, January 2010
  137. Number of pharmacy outlets operated by xxx in Bulgaria, by name, January 2010
  138. Number of pharmacy outlets in selected Central European countries, February 2010
  139. Mean population to pharmacy rate in selected Central European countries, February 2010
  140. Where did you buy medicines, personal care products, medical devices, etc. in 2009?

List of tables

  1. Annual average exchange rates used for this report (euro to national currency unit), 2006-2009
  2. Comparison of non-pharmacy sales of drugs in selected CE countries, 2010
  3. Comparison of online sales in selected CE countries, February 2010
  4. Characteristics of xxx warehouses in Bulgaria, 2010
  5. Characteristics of xxx warehouses in Bulgaria, 2010
  6. Number of wholesalers and wholesale warehouses in selected Central European countries, February 2010
  7. Market share of leading player and five largest wholesalers in selected Central European countries, February 2010
  8. Number of pharmacy outlets operated by xxx in the Czech Republic, by location (region), January 2010
  9. Number of pharmacy outlets operated by Pharmaland in the Czech Republic, by location, January 2010
  10. Number of pharmacy outlets operated by xxx in the Czech Republic, by location, January 2010
  11. Number of pharmacy outlets operated by xxx in the Czech Republic, by location, January 2010
  12. Leading pharmacy chains in selected Central European countries, February 2010
  13. Comparison of non-pharmacy sales of drugs in selected CE countries, 2010
  14. Comparison of online sales of drugs in selected CE countries, February 2010
Distribution on the pharmaceutical market in Central Europe 2010
Comparative analysis of Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria

Choose your version of this product:

Select
language:
Select
licence:
     Price: 2000
Language / Licence Single 5 Users Corporate Global
English2000300040005000

Compare licences
  • "Single user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of one computer belonging to the client;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "5-user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Corporate licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Global licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
    PMR is a member of SIIA's Corporate Content Anti-Piracy Program. Breaking the conditions of our licences will result in a report being sent to SIIA to initiate a piracy investigation and major fees may be imposed by the SIIA as a result. Additionally, for newsletters and online services, it will result in suspension of the subscription with no money refund.